IBT Staff Reporter

1081-1110 (out of 154944)

Teva Pharm Sees Return To Growth Post-opioid Settlement

Teva Pharmaceutical Industries projected on Wednesday mid-single digit revenue growth over the next five years as it tries to move on from its high debt and an overhang from thousands of lawsuits over its alleged role in the U.S.

Pages